BioAge Labs, Inc. — Director's Dealing 2025

Aug 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAge Labs, Inc. (BIOA)
CIK: 0001709941
Period of Report: 2025-08-07

Reporting Person: Pande Vijay Satyanand (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-07	Stock Option (Right to Buy)	$4.32	A	22000	Acquired	2035-08-06	Common Stock (22000)	Direct

Footnotes

F1: The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.